[감염병특허] |
감염병이 등장한 특허문서내 데이터기술 키워드 (미국특허) 감염병이 등장한 특허문서내 데이터기술 키워드
|
데이터 기본 이용료
|
데이터등록일 | 데이터 수정일 | 데이터 이용기한 | 판매제공처 |
---|---|---|---|
2022-12-08 | 2023-07-25 | 무기한 | BLT |
데이터 제공포맷 | 데이터 제공방식 | 데이터 파일용량 | 데이터 상품구분 |
csv/zip | 다운로드 | 677.53 MB | dataset |
■ 데이터상품설명 ICD 질병분류코드에 정의된 감염질환을 기준으로 질병별로 정리된 특허데이터를 가공해 제공합니다. 본 데이터 상품은 특허의 명칭/초록/청구항에서 자연어처리를 통해 기술키워드를 추출하여 알고리즘, 소프트웨어, 네트워크 등의 데이터기술 키워드만을 선별 제공하는것을 목적으로 하고 있으며, 감염질병정보/특허정보/키워드명/TF값/DF값 등의 정보가 수록되어있습니다. ■ 간략 통계 수록 감염병: 약 600종 (정의된 감염질환 1200여개에 대해 모두 스크리닝) 수록 특허수: 약 4만건 (2023년 02월 현재기준) 질병당 특허수 :평균 222건 (최소1 최대 6977건) 질병당 키워드수: 평균 1493개 (최소1 최대 56986개) ■ 데이터 내용설명 아래와 같은 데이터를 포함하고 있습니다 1) 질병정보 (질병ID/질병코드/질병명) 2) 특허번호정보 (특허ID/출원번호/등록번호) 3) 특허날짜정보 (출원일자/등록일자) 4) 특허권리자 5) 키워드정보 (키워드ID/키워드영어명/키워드한국어명) 6) 키워드통계 (TF값/DF값) ■ 참고: ICD10 질병분류코드 코로나바이러스감염증-19 [U07.1] 콜레라 [A00] 결핵 [A15-A19] 디프테리아 [A36] 패혈증 [A40-41] 크로이츠펠트-야콥병 [A81.0] 바이러스수막염 [A87] 지카 바이러스 질환 [A92.5] 황열 [A95] 뎅기 [A97] 에볼라바이러스병 [A98.4] 헤르페스바이러스[단순헤르페스] 감염 [B00] 대상포진 [B02] 바이러스간염 [B15-B19] 인체면역결핍바이러스병 [B20-B24] 감염성 단핵구증 [B27] 백선증 [B35] 칸디다증 [B37] 샤가스병 [B57] 연충증 [B65-B83] 메티실린 내성 황색포도상구균 [U82.1]
컨텐츠ID
|
컨텐츠영어명
|
컨텐츠한국어명
|
컨텐츠대분류명
|
질병분류코드
|
MESH분류코드
|
키워드ID
|
키워드영어명
|
키워드한국어명
|
TF값
|
DF값
|
국가코드
|
특허ID
|
특허출원번호
|
특허공개번호
|
특허등록번호
|
특허출원일자
|
특허출원공개일자
|
특허등록일자
|
특허최초공보발행일자
|
현재특허권리자그룹
|
특허발명의명칭제목
|
메인CPC특허분류코드
|
전체CPC특허분류코드목록
|
CPC특허분류코드개수
|
메인IPC특허분류코드
|
전체IPC특허분류코드목록
|
IPC특허분류코드개수
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
940636 | Sepsis | 패혈증 | 기타 세균성 질환 | A40-41 | 1496653282 | group | 그룹 | 1 | 4279 | US | US20180188195A1 | 15/738754 | 20180188195 | 20160627 | 20180705 | 20180705 | T2 Biosystems | SYSTEMS AND METHODS FOR MULTIPLEXED HEMOSTASIS TEST PANELS | G01N24/088 | G01N24/088|G01N2333/974|G01R33/448|G01N24/08|C12Q1/56 | 5 | G01N24/08 | G01N24/08|C12Q1/56|G01R33/44 | 3 | |||
941088 | HIV dementia | 인체면역결핍바이러스치매 | 인체면역결핍바이러스병 | B22.0.0 | 1844169497 | cadence data | 케이던스 데이터 | 5 | 1 | US | US00010694987B1 | 14/318477 | 10694987 | 20140627 | 20200630 | 20200630 | Neurametrix | Neurological disorder determining and monitoring system and method | A61B5/162 | A61B5/162|A61B5/4088|A61B5/4842|A61B5/4082 | 4 | A61B5/16 | A61B5/16 | 1 | |||
211685 | Rabies | 광견병 | 중추신경계통의 바이러스감염 | A82 | 1955097991 | given resolution | 주어진 해상도 | 5 | 1 | US | US20070009884A1 | 11/399192 | 20070009884 | 20060406 | 20070111 | 20070111 | Flir Detection | Methods and apparatuses for detecting chemical or biological agents | C12Q1/6813 | C12Q1/6813|B82Y5/00|Y02A50/30|B82Y10/00 | 4 | C12Q1/70 | C12Q1/70|C12M1/34|C12Q1/68 | 3 | |||
940456 | Infectious or septic | 감염성 또는 패혈성 | 장감염질환 | A09.0.6 | 1496653282 | group | 그룹 | 2 | 76 | US | US20220133818A1 | 17/433713 | 20220133818 | 20200226 | 20220505 | 20220505 | University of Colorado | METHOD AND COMPOSITION FOR TREATING GASTROINTESTINAL INFLAMMATORY DISORDERS | A61K35/745 | A61K35/745|A61K35/741|A61K35/747 | 3 | A61K35/745 | A61K35/745|A61K35/747 | 2 | |||
968871 | hepatitis C | C형간염 | 바이러스간염 | B17.1|B18.2 | 247533 | analytical system | 분석 시스템 | 5 | 2 | US | US00009274118B2 | 14/172237 | 20140221240 | 9274118 | 20140204 | 20140807 | 20160301 | 20140807 | Aspira Womens Health | Predictive markers for ovarian cancer | G01N33/57449 | G01N33/57449|G01N2800/52|G01N2800/50|Y02A90/10|G01N2800/60 | 5 | C40B30/04 | C40B30/04|G01N33/574 | 2 | |
211566 | Tuberculosis | 결핵 | 결핵 | A15-A19 | 1496653282 | group | 그룹 | 3 | 3535 | US | US00007749696B2 | 10/549495 | 20070015157 | 7749696 | 20040319 | 20070118 | 20100706 | 20070118 | Qiagen | Method and kit for the specific detection of M. tuberculosis | C12Q1/689 | C12Q1/689|C12Q2600/156 | 2 | C12Q1/68 | C12Q1/68|C07H21/04|C12P19/34 | 3 | |
968871 | hepatitis C | C형간염 | 바이러스간염 | B17.1|B18.2 | 1562537684 | hardware processor | 하드웨어 프로세서 | 15 | 2 | US | US20180330061A1 | 15/592064 | 20180330061 | 20170510 | 20181115 | 20181115 | Pinscriptive | Treatment Recommendation System And Method | G16H50/30 | G16H50/30|G16H50/20|G16H20/10 | 3 | G06F19/00 | G06F19/00 | 1 | |||
940636 | Sepsis | 패혈증 | 기타 세균성 질환 | A40-41 | 1496653282 | group | 그룹 | 4 | 4279 | US | US20220221474A1 | 17/710329 | 20220221474 | 20220331 | 20220714 | 20220714 | Brahms | METHOD FOR PREPARING A SAMPLE | G01N33/74 | G01N33/74|G01N2800/52|G01N2800/50|G01N2800/222|G01N33/86|A61P7/00 | 6 | G01N33/74 | G01N33/74|G01N33/86 | 2 | |||
940636 | Sepsis | 패혈증 | 기타 세균성 질환 | A40-41 | 1496653282 | group | 그룹 | 8 | 4279 | US | US20050080140A1 | 10/923348 | 20050080140 | 20040820 | 20050414 | 20050414 | Anges Mg | Method for treating or preventing inflammatory disorders | A61K31/00 | A61K31/00|A61K48/005|A61K31/557|C12N9/90|A61P29/00 | 5 | A61K31/557 | A61K31/557 | 1 | |||
211630 | Diphtheria | 디프테리아 | 기타 세균성 질환 | A36 | 1496653282 | group | 그룹 | 23 | 2111 | US | US00004384995B | 06/323690 | 4384995 | 19811120 | 19830524 | 19830524 | The Ohio State University | Antigenic modification of polypeptides | A61K39/0006 | A61K39/0006|A61K38/00|A61K2039/6012|Y10S424/811|Y10S530/806|Y10S930/11|A61K2039/5555 | 7 | A61K39/00 | A61K39/00|A61K38/00 | 2 | |||
211726 | Human immunodeficiency virus [HIV] disease | 인체면역결핍바이러스병 | 인체면역결핍바이러스병 | B20-B24 | 74882 | active agent | 활성제 | 1 | 140 | US | US00006399574B1 | 09/533889 | 6399574 | 20000322 | 20020604 | 20020604 | University of Utah | Use of conantokins | C07K14/43504 | C07K14/43504|A61K38/00 | 2 | A61K38/00 | A61K38/00|C07K5/00|C07K7/00|C07K14/435 | 4 | |||
211538 | Other bacterial intestinal infections | 기타 세균성 장감염 | 장감염질환 | A04 | 1965984075 | achieving object | 목표 달성 | 5 | 1 | US | US00006197574B1 | 09/101269 | 6197574 | 19990125 | 20010306 | 20010306 | Fujirebio | Bacterium detector | C12M23/06 | C12M23/06|C12M33/02|C12M29/26|C12M23/38|Y02A50/30 | 5 | C12M1/30 | C12M1/30|C12Q1/24|C12M1/28 | 3 | |||
211566 | Tuberculosis | 결핵 | 결핵 | A15-A19 | 1496653282 | group | 그룹 | 4 | 3535 | US | US00007132096B2 | 10/813322 | 20040266838 | 7132096 | 20040329 | 20041230 | 20061107 | 20041230 | Columbia University | Antimicrobial activity of gemfibrozil | A61K31/192 | A61K31/192|Y02A50/30 | 2 | A61K49/00 | A61K49/00|A61K31/192 | 2 | |
211624 | Leprosy [Hansen disease] | 나병[한센병] | 기타 세균성 질환 | A30 | 1831001686 | emotive response | 감동적인 반응 | 3 | 2 | US | US20080040082A1 | 11/788079 | 20080040082 | 20070419 | 20080214 | 20080214 | P&G (Procter & Gamble) | Modeling systems for consumer goods | G06Q10/04 | G06Q10/04|G16C20/70|G16C20/50|G06Q10/067 | 4 | G06G7/48 | G06G7/48 | 1 | |||
940636 | Sepsis | 패혈증 | 기타 세균성 질환 | A40-41 | 3211608 | medical record | 의료 기록 | 11 | 42 | US | US20090281838A1 | 12/437385 | 20090281838 | 20090507 | 20091112 | 20091112 | Lawrence A. Lynn | MEDICAL FAILURE PATTERN SEARCH ENGINE | G16H50/80 | G16H50/80|G16H50/70|G16H50/20|G16H15/00|G16H10/60 | 5 | G06Q50/00 | G06Q50/00 | 1 | |||
211713 | Zoster [herpes zoster] | 대상포진 | 피부 및 점막병변이 특징인 바이러스감염 | B02 | 2400437 | herpesvirus type | 헤르페스바이러스 타입 | 1 | 38 | US | US20170087225A1 | 15/277675 | 20170087225 | 20160927 | 20170330 | 20170330 | Agenovir | COMPOSITIONS AND METHODS FOR LATENT VIRAL TRANSCRIPTION REGULATION | A61K38/465 | A61K38/465|C12N9/22|Y02A50/30|A61P31/12|C12N2310/20|A61K47/549|C12Y301/00|C12N15/1131 | 8 | A61K38/46 | A61K38/46|A61K47/48 | 2 | |||
211713 | Zoster [herpes zoster] | 대상포진 | 피부 및 점막병변이 특징인 바이러스감염 | B02 | 1496653282 | group | 그룹 | 38 | 1342 | US | US20050261251A1 | 11/093648 | 20050261251 | 20050330 | 20051124 | 20051124 | Vion Pharmaceuticals|Yale University | Antiviral agents and methods of treating viral infections | A61K31/44 | A61K31/44|Y02A50/30 | 2 | A61K0/31675 | A61K0/31675|A61K0/3144 | 2 | |||
211630 | Diphtheria | 디프테리아 | 기타 세균성 질환 | A36 | 2373141 | health record | 건강기록 | 1 | 1 | US | US00010788482B2 | 15/599775 | 20170322203 | 10788482 | 20170519 | 20171109 | 20200929 | 20171109 | Immunoprofile | Immunization testing system | G01N33/53 | G01N33/53|Y02A90/10|G01N33/6854 | 3 | G01N33/53 | G01N33/53|G01N33/68 | 2 | |
940906 | Japanese encephalitis | 일본뇌염 | 중추신경계통의 바이러스감염 | A83.0 | 1496653282 | group | 그룹 | 3 | 597 | US | US20060292031A1 | 11/180278 | 20060292031 | 20050712 | 20061228 | 20061228 | Tex-Ray Industrial | Method of inactivating viruses associated with biomaterial | A61L2/0088 | A61L2/0088 | 1 | A61L2/18 | A61L2/18 | 1 | |||
968871 | hepatitis C | C형간염 | 바이러스간염 | B17.1|B18.2 | 1496653282 | group | 그룹 | 34 | 4096 | US | US20130196903A1 | 13/816163 | 20130196903 | 20110811 | 20130801 | 20130801 | JV Bio | Multimeric Inhibitors of Viral Fusion and Uses Thereof | A61K47/554 | A61K47/554|Y02A50/30|C12N2740/16063|A61K38/00|A61K47/60 | 5 | A61K47/48 | A61K47/48 | 1 | |||
968870 | hepatitis B | B형간염 | 바이러스간염 | B16|B18.0-1 | 1496653282 | group | 그룹 | 9 | 3567 | US | US20210346400A1 | 17/211033 | 20210346400 | 20210324 | 20211111 | 20211111 | Intercept Pharmaceuticals | TREATMENT OF FIBROSIS USING FXR LIGANDS | A61K31/575 | A61K31/575|A61K9/0053|A61P1/16 | 3 | A61K31/575 | A61K31/575|A61P1/16|A61K9/00 | 3 | |||
968870 | hepatitis B | B형간염 | 바이러스간염 | B16|B18.0-1 | 3517126 | non coding | 비-암호화 | 1 | 20 | US | US20100323344A1 | 12/802981 | 20100323344 | 20100617 | 20101223 | 20101223 | University of Texas System | Detection of hepatitis C virus RNA | C12Q1/707 | C12Q1/707 | 1 | C12Q1/70 | C12Q1/70 | 1 | |||
940636 | Sepsis | 패혈증 | 기타 세균성 질환 | A40-41 | 4474353 | record system | 기록 시스템 | 8 | 7 | US | US20120089421A1 | 13/269262 | 20120089421 | 20111007 | 20120412 | 20120412 | Cerner Innovation | MULTI-SITE CLINICAL DECISION SUPPORT FOR SEPSIS | G16H10/60 | G16H10/60|G16H40/67|G16H15/00|G16H50/30|G16H50/20 | 5 | G06Q50/24 | G06Q50/24 | 1 | |||
940636 | Sepsis | 패혈증 | 기타 세균성 질환 | A40-41 | 3476809 | nervous system | 신경계 | 2 | 419 | US | US00005696156B | 08/733037 | 5696156 | 19961016 | 19971209 | 19971209 | MSD (Merck & Company) | Triterpene derivatives with immunosuppressant activity | C07D313/06 | C07D313/06 | 1 | A61K31/365 | A61K31/365|C07D313/06 | 2 | |||
211623 | Other bacterial diseases | 기타 세균성 질환 | 기타 세균성 질환 | A30-A49 | 1505189828 | neutral group | 중립 그룹 | 1 | 5 | US | US00008835380B2 | 13/805888 | 20130096049 | 8835380 | 20110601 | 20130418 | 20140916 | 20130418 | Cardiff University | Therapeutic conjugates | A61K45/06 | A61K45/06|A61K47/61|A61P31/04 | 3 | A61K45/06 | A61K45/06|A61K47/48 | 2 | |
968874 | Malaria | 말라리아 | 원충질환 | B50-B54 | 2298510 | graft versus host | 이식편대숙주 | 1 | 211 | US | US00006518281B2 | 09/909506 | 20020002188 | 6518281 | 20010720 | 20020103 | 20030211 | 20020103 | Celgene | Immunotherapeutic agents | C07D209/48 | C07D209/48|C07D209/46|A61P35/02|A61P35/00 | 4 | A61P35/00 | A61P35/00|A61P35/02|C07D209/48|C07D209/46 | 4 | |
211609 | Anthrax | 탄저병 | 특정 동물매개의 세균성 질환 | A22 | 519796 | biological agent | 생물학적 작용제 | 15 | 39 | US | US20060148068A1 | 10/541617 | 20060148068 | 20040108 | 20060706 | 20060706 | Noury, Jacques | Biological sensor | C12M33/02 | C12M33/02|C12M23/32|C12M23/22|C12M41/12|C12M23/06|C12M33/04|C12M23/38 | 7 | C12M1/34 | C12M1/34 | 1 | |||
211623 | Other bacterial diseases | 기타 세균성 질환 | 기타 세균성 질환 | A30-A49 | 1496653282 | group | 그룹 | 45 | 8962 | US | US20200181153A1 | 16/708850 | 20200181153 | 20191210 | 20200611 | 20200611 | Chinook Therapeutics | IMIDAZOPYRIDAZINONE COMPOUNDS AND USES THEREOF | C07D487/04 | C07D487/04|A61K45/06|A61P29/00 | 3 | C07D487/04 | C07D487/04 | 1 | |||
211631 | Whooping cough | 백일해 | 기타 세균성 질환 | A37 | 1762122181 | communicating instruction | 의사 소통 지시 | 1 | 1 | US | US20150196269A1 | 14/156108 | 20150196269 | 20140115 | 20150716 | 20150716 | Xerox | SYSTEM AND METHOD FOR REMOTE DETERMINATION OF ACUTE RESPIRATORY INFECTION | A61B7/003 | A61B7/003|A61B7/04|A61B5/0823 | 3 | A61B7/00 | A61B7/00|A61B7/04 | 2 | |||
968870 | hepatitis B | B형간염 | 바이러스간염 | B16|B18.0-1 | 1496653282 | group | 그룹 | 4 | 3567 | US | US20160039879A1 | 14/775101 | 20160039879 | 20140317 | 20160211 | 20160211 | S&T | NOVEL CYCLOSPORIN DERIVATIVES AND USES THEREOF | C07K7/645 | C07K7/645|A61K38/00 | 2 | C07K7/64 | C07K7/64 | 1 | |||
968874 | Malaria | 말라리아 | 원충질환 | B50-B54 | 5890902 | visual display | 시각 디스플레이 | 2 | 1 | US | US00005658322B | 08/541182 | 5658322 | 19951011 | 19970819 | 19970819 | Regeneration Technology | Bio-active frequency generator and method | A61N1/40 | A61N1/40|A61N1/326 | 2 | A61N1/18 | A61N1/18|A61N1/40|A61N1/32 | 3 | |||
211566 | Tuberculosis | 결핵 | 결핵 | A15-A19 | 1752183187 | heterocyclic group | 복소환기 | 3 | 40 | US | US00009481683B2 | 14/734095 | 20150353571 | 9481683 | 20150609 | 20151210 | 20161101 | 20151210 | University of Notre Dame du Lac (ND) | 1,3-benzothiazinone sulfoxide and sulfone compounds | C07D491/113 | C07D491/113 | 1 | C07D491/113 | C07D491/113 | 1 | |
211610 | Brucellosis | 브루셀라병 | 특정 동물매개의 세균성 질환 | A23 | 3600359 | OCF | OCF | 2 | 8 | US | US20210253577A1 | 16/972775 | 20210253577 | 20190606 | 20210819 | 20210819 | Bioversys | BIODEFENSE AGENTS | C07D487/04 | C07D487/04|A61P31/04|A61K31/519|Y02A50/30 | 4 | C07D487/04 | C07D487/04|A61P31/04 | 2 | |||
211719 | Viral hepatitis | 바이러스간염 | 바이러스간염 | B15-B19 | 2260985 | generating magnetic field | 자계 생성 | 1 | 1 | US | US20200330782A1 | 16/908990 | 20200330782 | 20200623 | 20201022 | 20201022 | Jacob Zabara | ELECTROMAGNETIC RADIATION TREATMENT | A61N2/004 | A61N2/004|A61N2/02|A61N2/002 | 3 | A61N2/00 | A61N2/00|A61N2/02 | 2 | |||
211774 | Protozoal diseases | 원충질환 | 원충질환 | B50-B64 | 3956633 | phosphorus containing group | 인 함유 그룹 | 1 | 3 | US | US00006525028B1 | 10/068831 | 6525028 | 20020204 | 20030225 | 20030225 | Corixa | Immunoeffector compounds | C07H15/26 | C07H15/26 | 1 | A61K51/00 | A61K51/00|C07H15/00|C07G11/00|A01N43/04|A61K49/04|C07H15/26 | 6 | |||
211523 | Intestinal infectious diseases | 장감염질환 | 장감염질환 | A00-A09 | 4493897 | reducing agent | 환원제 | 1 | 9 | US | US00009422595B2 | 14/377013 | 20140370514 | 9422595 | 20130218 | 20141218 | 20160823 | 20141218 | Biotec Pharmacon | Endonucleases | C12N9/22 | C12N9/22|C12Y301/21001|C12Q1/6806|C12Q2521/301 | 4 | C12Q1/00 | C12Q1/00|C12N9/22|C12N9/00|C12Q1/68 | 4 | |
211566 | Tuberculosis | 결핵 | 결핵 | A15-A19 | 1470475603 | display of result | 결과 표시 | 1 | 1 | US | US20210278402A1 | 17/261202 | 20210278402 | 20191126 | 20210909 | 20210909 | Module Innovations Private | METHOD FOR TESTING OF ANTIBIOTIC SUSCEPTIBILITY IN MICROORGANISMS | G01N33/553 | G01N33/553|C12Q1/18|G01N2333/904|G01N33/5308 | 4 | G01N33/553 | G01N33/553|G01N33/53 | 2 | |||
211606 | Certain zoonotic bacterial diseases | 특정 동물매개의 세균성 질환 | 특정 동물매개의 세균성 질환 | A20-A28 | 1691216 | electrical field | 전장 | 1 | 4 | US | US20080176196A1 | 12/008449 | 20080176196 | 20080111 | 20080724 | 20080724 | Lee, G A | Natural process and new techniques for sterilization | G09B19/0076 | G09B19/0076 | 1 | G09B19/00 | G09B19/00 | 1 | |||
211623 | Other bacterial diseases | 기타 세균성 질환 | 기타 세균성 질환 | A30-A49 | 5783720 | urinary tract | 요로 | 2 | 394 | US | US00011129843B2 | 16/607531 | 20200069711 | 11129843 | 20180423 | 20200305 | 20210928 | 20200305 | Elysium Health | Treating and preventing kidney damage | A61K31/706 | A61K31/706|A61P13/12|A61P9/00|A61K31/09 | 4 | A61K31/706 | A61K31/706|A61K31/09|A61P13/12 | 3 | |
211630 | Diphtheria | 디프테리아 | 기타 세균성 질환 | A36 | 1944358 | farnesyl group | 파네실기 | 1 | 8 | US | US20050063952A1 | 10/893018 | 20050063952 | 20040716 | 20050324 | 20050324 | Pharmexa | Immunogenic CEA | A61K39/001182 | A61K39/001182|A61K2039/5256|A61K2039/523|Y02A50/30|C07K14/70503|A61K2039/6031|A61P35/00|A61K2039/53 | 8 | C12N15/86 | C12N15/86|A61K48/00 | 2 | |||
940836 | Noma | 노마 | 기타 스피로헤타질환 | A69.0.2 | 1425856 | device information | 디바이스 정보 | 1 | 2 | US | US20180192424A1 | 15/906393 | 20180192424 | 20180227 | 20180705 | 20180705 | Fujitsu | Information Transmission Apparatus and Method and Communications System | H04W72/0473 | H04W72/0473|H04L27/3444|H04L27/3411 | 3 | H04W72/04 | H04W72/04|H04L27/34 | 2 | |||
968866 | Tetanus | 파상풍 | 기타 세균성 질환 | A33-35 | 2548388 | imaging agent | 이미징제 | 1 | 11 | US | US20080268021A1 | 12/215101 | 20080268021 | 20080624 | 20081030 | 20081030 | Arius Two | Adhesive bioerodible ocular drug delivery system | A61K9/0051 | A61K9/0051|A61K9/7023 | 2 | A61K9/70 | A61K9/70|A61K31/403|A61K31/4523 | 3 | |||
211630 | Diphtheria | 디프테리아 | 기타 세균성 질환 | A36 | 1496653282 | group | 그룹 | 3 | 2111 | US | US00010788482B2 | 15/599775 | 20170322203 | 10788482 | 20170519 | 20171109 | 20200929 | 20171109 | Immunoprofile | Immunization testing system | G01N33/53 | G01N33/53|Y02A90/10|G01N33/6854 | 3 | G01N33/53 | G01N33/53|G01N33/68 | 2 | |
211774 | Protozoal diseases | 원충질환 | 원충질환 | B50-B64 | 2298510 | graft versus host | 이식편대숙주 | 2 | 272 | US | US20060173080A1 | 11/291730 | 20060173080 | 20051201 | 20060803 | 20060803 | University of California | Methods of modulating TNF using bupropion | A61K31/137 | A61K31/137|Y02A50/30 | 2 | A61K31/137 | A61K31/137 | 1 | |||
940543 | Cutaneous anthrax | 피부탄저병 | 특정 동물매개의 세균성 질환 | A22.0 | 3600359 | OCF | OCF | 3 | 2 | US | US20210206782A1 | 16/268637 | 20210206782 | 20190206 | 20210708 | 20210708 | Techfields Pharma | HIGH PENETRATION PRODRUG COMPOSITIONS OF ANTIMICROBIALS AND ANTIMICROBIAL-RELATED COMPOUNDS | C07D499/00 | C07D499/00|A61P31/04 | 2 | C07D499/00 | C07D499/00|A61P31/04 | 2 | |||
211566 | Tuberculosis | 결핵 | 결핵 | A15-A19 | 1496653282 | group | 그룹 | 4 | 3535 | US | US00010751072B2 | 15/401950 | 20170182301 | 10751072 | 20170109 | 20170629 | 20200825 | 20170629 | Vaxxas | Delivery device | A61B17/205 | A61B17/205|A61M2037/0046|B33Y80/00|A61M37/0015 | 4 | A61B17/20 | A61B17/20|A61M37/00|B33Y80/00 | 3 | |
211719 | Viral hepatitis | 바이러스간염 | 바이러스간염 | B15-B19 | 4524039 | region information | 영역 정보 | 5 | 2 | US | US20070259339A1 | 11/615789 | 20070259339 | 20061222 | 20071108 | 20071108 | Siemens Healthineers | METHODS AND REAGENTS FOR GENOTYPING HCV | C12Q1/707 | C12Q1/707|C12N2770/24211 | 2 | C12Q1/70 | C12Q1/70|C07H21/04 | 2 | |||
211724 | Acute hepatitis E | 급성 E형간염 | 바이러스간염 | B17.2 | 1478246 | dig | 굴착 | 1 | 1 | US | US20140094383A1 | 14/044631 | 20140094383 | 20131002 | 20140403 | 20140403 | The Ohio State University | Tethered Lipoplex nanoparticle Biochips And Methods Of Use | G01N33/56983 | G01N33/56983|Y02A50/30|G01N33/5432 | 3 | G01N33/569 | G01N33/569 | 1 | |||
211527 | Typhoid and paratyphoid fevers | 장티푸스 및 파라티푸스 | 장감염질환 | A01 | 5363557 | surface functional group | 표면 작용기 | 1 | 1 | US | US00008084247B2 | 12/658214 | 20100151563 | 8084247 | 20100204 | 20100617 | 20111227 | 20100617 | American Sterilizer | Biological indicator | G01N33/54353 | G01N33/54353|C12Q1/22 | 2 | C12M1/34 | C12M1/34 | 1 | |
211720 | Acute hepatitis A | 급성 A형간염 | 바이러스간염 | B15 | 608175 | brucella species | brucella species | 2 | 38 | US | US20080050718A1 | 10/583198 | 20080050718 | 20041115 | 20080228 | 20080228 | University of Utah | Methods, Articles, and Compositions for Identifying Oligonucleotides | G16B25/20 | G16B25/20|G16B25/00 | 2 | C12Q1/68 | C12Q1/68|C12Q1/70|C07H21/04 | 3 | |||
941051 | Vaccinia | 우두 | 피부 및 점막병변이 특징인 바이러스감염 | B08.0.3 | 1628044075 | inducing immune response | 면역 반응 유도 | 1 | 213 | US | US20050069976A1 | 10/467492 | 20050069976 | 20010214 | 20050331 | 20050331 | Pharmacia & Upjohn | Protein-coupled receptor | C07K14/705 | C07K14/705|A61K38/00|C07H21/04 | 3 | C07K14/705 | C07K14/705|C07H21/04 | 2 | |||
941134 | Tinea unguium | 손발톱백선 | 진균증 | B35.1 | 1496653282 | group | 그룹 | 3 | 279 | US | US20100228180A1 | 12/223178 | 20100228180 | 20070125 | 20100909 | 20100909 | Power Paper | Power Source Electrode Treatment Device | A61N1/0436 | A61N1/0436|A61N1/0424|A61N1/042|A61N1/30|A61N1/20|A61N1/044 | 6 | A61N1/30 | A61N1/30 | 1 | |||
968874 | Malaria | 말라리아 | 원충질환 | B50-B54 | 3235372 | MER | MER | 5 | 7 | US | US20020136733A1 | 10/042202 | 20020136733 | 20020111 | 20020926 | 20020926 | Oxxon Therapeutics | Malaria peptides | C07K14/445 | C07K14/445|Y02A50/30|A61K39/00 | 3 | C07K14/74 | C07K14/74|A61K39/00 | 2 | |||
211673 | Other spirochaetal infections | 기타 스피로헤타감염 | 기타 스피로헤타질환 | A69 | 5181452 | spread data | 확산 데이터 | 3 | 3 | US | US20210399849A1 | 17/467375 | 20210399849 | 20210906 | 20211223 | 20211223 | TYBALT | Non-Orthogonal Multiple Access | H04L5/0005 | H04L5/0005|H04J99/00 | 2 | H04L5/00 | H04L5/00|H04J99/00 | 2 | |||
940636 | Sepsis | 패혈증 | 기타 세균성 질환 | A40-41 | 1804591891 | prognosis of sepsis | 패혈증의 예후 | 10 | 16 | US | US20160244834A1 | 14/900416 | 20160244834 | 20140627 | 20160825 | 20160825 | Acumen Res Lab | SEPSIS BIOMARKERS AND USES THEREOF | C12Q1/6883 | C12Q1/6883|C12Q2600/118|C12Q2600/158 | 3 | C12Q1/68 | C12Q1/68 | 1 | |||
211623 | Other bacterial diseases | 기타 세균성 질환 | 기타 세균성 질환 | A30-A49 | 104842248 | multivalent type | 다가 유형 | 1 | 10 | US | US20070224252A1 | 11/391609 | 20070224252 | 20060327 | 20070927 | 20070927 | Alza | Microprojections with capillary control features and method | A61M37/0015 | A61M37/0015|A61M2037/0046|A61K9/0021 | 3 | A61K9/70 | A61K9/70|A61M31/00 | 2 | |||
211713 | Zoster [herpes zoster] | 대상포진 | 피부 및 점막병변이 특징인 바이러스감염 | B02 | 1496653282 | group | 그룹 | 2 | 1342 | US | US00006673828B1 | 09/309464 | 6673828 | 19990511 | 20040106 | 20040106 | Children's Medical Center | Analogs of 2-Phthalimidinoglutaric acid | C07D209/46 | C07D209/46 | 1 | A61K31/4035 | A61K31/4035|C07D209/46 | 2 | |||
211740 | Mycoses | 진균증 | 진균증 | B35-B49 | 74882 | active agent | 활성제 | 7 | 203 | US | US20090280069A1 | 12/463028 | 20090280069 | 20090508 | 20091112 | 20091112 | Tolmar | PROGUANIL TO TREAT SKIN/MUCOSAL DISEASES | A61K9/0014 | A61K9/0014|A61K31/155|Y02A50/30|A61K9/0034|A61K9/122|A61P17/00|A61P9/00 | 7 | A61K9/12 | A61K9/12|A01N37/52|A61K31/155 | 3 | |||
940846 | Lyme disease | 라임병 | 기타 스피로헤타질환 | A69.2 | 3476809 | nervous system | 신경계 | 1 | 86 | US | US20210077570A1 | 16/971867 | 20210077570 | 20190217 | 20210318 | 20210318 | Galenus G.H | COMPOSITION COMPRISING A POLYMYXIN AND TEICOPLANIN | A61K38/12 | A61K38/12|Y02A50/30|A61P31/04|A61K38/14 | 4 | A61K38/12 | A61K38/12|A61K38/14|A61P31/04 | 3 | |||
211624 | Leprosy [Hansen disease] | 나병[한센병] | 기타 세균성 질환 | A30 | 1403911959 | content of dispersion | 분산의 내용 | 12 | 1 | US | US20220328801A1 | 17/710057 | 20220328801 | 20220331 | 20221013 | 20221013 | Toyota Motor | ANODE SLURRY | H01M4/0416 | H01M4/0416|H01M4/386|Y02E60/10 | 3 | H01M4/04 | H01M4/04|H01M4/38 | 2 | |||
211719 | Viral hepatitis | 바이러스간염 | 바이러스간염 | B15-B19 | 1733880910 | indication of likelihood | 가능성의 표시 | 1 | 8 | US | US20100203506A1 | 12/117869 | 20100203506 | 20080509 | 20100812 | 20100812 | Melbourne Health | VIRAL VARIANTS AND METHODS FOR DETECTING SAME | C12N7/00 | C12N7/00|C12N2730/10122|C12N9/1276|C07K14/005 | 4 | C12N7/01 | C12N7/01|C12Q1/68 | 2 | |||
211566 | Tuberculosis | 결핵 | 결핵 | A15-A19 | 1042175651 | physician information | 의사 정보 | 4 | 3 | US | US20100320099A1 | 12/777606 | 20100320099 | 20100511 | 20101223 | 20101223 | Sanofi | METHODS FOR REDUCING RISK | G09B19/00 | G09B19/00|A61K31/343 | 2 | A61J1/00 | A61J1/00|G09B19/00 | 2 | |||
211685 | Rabies | 광견병 | 중추신경계통의 바이러스감염 | A82 | 2553287 | immune response | 면역반응 | 2 | 378 | US | US20060171960A1 | 11/321389 | 20060171960 | 20051229 | 20060803 | 20060803 | Wyeth | Methods and composition for oral vaccination | A61K39/0241 | A61K39/0241|A61K2039/522|A61P37/04|A61P31/00|A61K2039/552|A61K9/0095|A61K2039/542 | 7 | A61K39/295 | A61K39/295 | 1 | |||
211786 | Helminthiases | 연충증 | 연충증 | B65-B83 | 3476809 | nervous system | 신경계 | 1 | 87 | US | US20210309669A1 | 17/260247 | 20210309669 | 20190710 | 20211007 | 20211007 | Pfizer | Heterocyclic Spiro Compounds As MAGL Inhibitors | C07D498/10 | C07D498/10|C07D491/107|A61P3/00|A61P37/00|A61P35/00|A61P25/00|A61P9/00 | 7 | C07D491/107 | C07D491/107 | 1 | |||
968871 | hepatitis C | C형간염 | 바이러스간염 | B17.1|B18.2 | 1496653282 | group | 그룹 | 2 | 4096 | US | US20070218033A1 | 11/801834 | 20070218033 | 20070511 | 20070920 | 20070920 | Sherman Kenneth | Composition and method of treating hepatitis C | A61K38/2292 | A61K38/2292|A61P37/00|A61P31/14|A61P31/12|A61P1/16 | 5 | A61P1/16 | A61P1/16|A61K38/21 | 2 | |||
211566 | Tuberculosis | 결핵 | 결핵 | A15-A19 | 1496653282 | group | 그룹 | 48 | 3535 | US | US20190194179A1 | 16/327286 | 20190194179 | 20170822 | 20190627 | 20190627 | Discuva | ANTIBIOTIC COMPOUNDS | C07D413/12 | C07D413/12|C07D413/14|A61P31/04|C07D417/12 | 4 | C07D413/12 | C07D413/12|C07D413/14|C07D417/12|A61P31/04 | 4 | |||
211610 | Brucellosis | 브루셀라병 | 특정 동물매개의 세균성 질환 | A23 | 608175 | brucella species | brucella species | 2 | 27 | US | US20210253577A1 | 16/972775 | 20210253577 | 20190606 | 20210819 | 20210819 | Bioversys | BIODEFENSE AGENTS | C07D487/04 | C07D487/04|A61P31/04|A61K31/519|Y02A50/30 | 4 | C07D487/04 | C07D487/04|A61P31/04 | 2 | |||
211624 | Leprosy [Hansen disease] | 나병[한센병] | 기타 세균성 질환 | A30 | 4344117 | quadratic regression | 2 차 회귀 | 2 | 1 | US | US00005671734B | 08/552818 | 5671734 | 5671734 | 19951103 | 19970930 | 19970930 | 19970930 | United States Navy | Automatic medical sign monitor | G16H40/63 | G16H40/63|G16H15/00|G16H20/13 | 3 | A61B5/00 | A61B5/00|G06F19/00 | 2 | |
211719 | Viral hepatitis | 바이러스간염 | 바이러스간염 | B15-B19 | 4588869 | request statement | 요청 문 | 1 | 1 | US | US20100217729A1 | 12/738858 | 20100217729 | 20081117 | 20100826 | 20100826 | Takahashi Yuusaku | SHAVER DISINFECTION SYSTEM FOR EACH CUSTOMER TYPE | A45D27/46 | A45D27/46|G06Q99/00 | 2 | G06Q90/00 | G06Q90/00|A61L2/04 | 2 | |||
211623 | Other bacterial diseases | 기타 세균성 질환 | 기타 세균성 질환 | A30-A49 | 1496653282 | group | 그룹 | 44 | 8962 | US | US00006177440B1 | 09/063066 | 6177440 | 19980421 | 20010123 | 20010123 | Eli Lilly and Company | Substituted tricyclics | C07D209/88 | C07D209/88 | 1 | C07D491/052 | C07D491/052|C07D209/88 | 2 | |||
968874 | Malaria | 말라리아 | 원충질환 | B50-B54 | 1607359188 | communicated measurement data | 통신 측정 데이터 | 1 | 1 | US | US20170331524A1 | 15/526375 | 20170331524 | 20151111 | 20171116 | 20171116 | Mc10 | SYSTEM, DEVICE, AND METHOD FOR ELECTRONIC DEVICE ACTIVATION | H04B5/0075 | H04B5/0075|H04B5/0031|H04B5/0037 | 3 | H04B5/00 | H04B5/00 | 1 | |||
940560 | Malleus | 비저 | 특정 동물매개의 세균성 질환 | A24.0.2 | 1878112210 | response to audio | 오디오에 대한 응답 | 5 | 7 | US | US00005797834B | 08/655773 | 5797834 | 19960531 | 19980825 | 19980825 | Goode, Richard L | Hearing improvement device | A61F2/18 | A61F2/18|A61F11/30|A61F2002/183|H04R25/606 | 4 | H04R25/02 | H04R25/02|A61F11/00|H04R25/00|A61F2/18 | 4 | |||
951381 | COVID-19 | 코로나바이러스감염증-19 | COVID-19 | U07.1 | 1496653282 | group | 그룹 | 1 | 504 | US | US20220202853A1 | 17/562871 | 20220202853 | 20211227 | 20220630 | 20220630 | Briotech | HYPOHALOUS ACIDS FOR TREATING INFLAMMATORY DISEASES AND INHIBITING GROWTH OF MALIGNANCIES | A61K33/20 | A61K33/20|A61K33/22|A61K33/00 | 3 | A61K33/20 | A61K33/20|A61K33/22 | 2 | |||
968866 | Tetanus | 파상풍 | 기타 세균성 질환 | A33-35 | 4896508 | sequence ID | 시퀀스 ID | 1 | 5 | US | US20140105927A1 | 13/827203 | 20140105927 | 20130314 | 20140417 | 20140417 | GSK (GLaxoSmithKline) Biologicals | IMMUNOGENIC COMPOSITION | A61K39/092 | A61K39/092|A61K2039/6037|A61K2039/55505|A61K2039/70|A61K2039/6056 | 5 | A61K39/09 | A61K39/09 | 1 | |||
968870 | hepatitis B | B형간염 | 바이러스간염 | B16|B18.0-1 | 1496653282 | group | 그룹 | 3 | 3567 | US | US20070281294A1 | 10/587386 | 20070281294 | 20050208 | 20071206 | 20071206 | Roche Molecular Systems | Primers And Probes For The Detection Of Parvovirus B19 | C12Q1/701 | C12Q1/701 | 1 | C12Q1/70 | C12Q1/70|C12N9/00|C07H21/04 | 3 | |||
968874 | Malaria | 말라리아 | 원충질환 | B50-B54 | 74882 | active agent | 활성제 | 1 | 97 | US | US00010370385B2 | 15/325320 | 20170166580 | 10370385 | 20150710 | 20170615 | 20190806 | 20170615 | University of Arizona | Tricyclic mosquitocides and methods of making and using thereof | C07D495/04 | C07D495/04|A01N43/90|Y02A50/30 | 3 | C07D495/04 | C07D495/04|A01N43/90 | 2 | |
968866 | Tetanus | 파상풍 | 기타 세균성 질환 | A33-35 | 4271198 | prognosis | 예후 | 1 | 13 | US | US20100204055A1 | 12/631824 | 20100204055 | 20091205 | 20100812 | 20100812 | Bonner-Ferraby Phoebe W|Hepburne-Scott Henry|McCormick Ann | AUTOANTIBODY DETECTION SYSTEMS AND METHODS | G01N33/564 | G01N33/564|G01N33/57407 | 2 | C40B30/04 | C40B30/04|C40B40/10 | 2 | |||
211750 | Blastomycosis | 분아균증 | 진균증 | B40 | 735880 | cellular carrier | 셀룰러 캐리어 | 2 | 1 | US | US20060182685A1 | 11/221294 | 20060182685 | 20050906 | 20060817 | 20060817 | Karakousis Petros C | Hollow fiber technique for in vivo study of cell populations | G01N33/5088 | G01N33/5088|C12Q1/02|A61K47/6953 | 3 | A61K49/00 | A61K49/00|C12Q1/00 | 2 | |||
211612 | Glanders | 마비저 | 특정 동물매개의 세균성 질환 | A24.0 | 1703295591 | identifying agent | 식별 에이전트 | 2 | 2 | US | US20220031672A1 | 17/279015 | 20220031672 | 20191004 | 20220203 | 20220203 | California, Univerisity Of, Los Angeles | DISCOVERY OF NOVEL ANTI-INFECTIVES FOR GRAM NEGATIVE PATHOGENS | A61K31/436 | A61K31/436|A61P31/04 | 2 | A61K31/436 | A61K31/436|A61P31/04 | 2 | |||
211623 | Other bacterial diseases | 기타 세균성 질환 | 기타 세균성 질환 | A30-A49 | 4823597 | SED | SED | 2 | 22 | US | US20100093082A1 | 12/440012 | 20100093082 | 20070907 | 20100415 | 20100415 | Ambrx | Site Specific Incorporation of Non-Natural Amino Acids by Vertebrate Cells | C12N9/93 | C12N9/93|C12P21/02 | 2 | C12N5/10 | C12N5/10 | 1 | |||
940584 | Infection due to Mycobacterium avium | Mycobacterium avium으로 인한 감염 | 기타 세균성 질환 | A31.0.0 | 1286415567 | present object | 현재 개체 | 5 | 5 | US | US20060211014A1 | 11/329206 | 20060211014 | 20060111 | 20060921 | 20060921 | Fujifilm | Method for detecting bacteria of the genus Mycobacterium (acid-fast bacteria) and kit for the same | C12Q1/689 | C12Q1/689 | 1 | C12Q1/68 | C12Q1/68|C12P19/34 | 2 | |||
940636 | Sepsis | 패혈증 | 기타 세균성 질환 | A40-41 | 1376123108 | profile of patient | 환자의 프로필 | 2 | 2 | US | US00008173437B2 | 11/450500 | 20070087440 | 8173437 | 20060609 | 20070419 | 20120508 | 20070419 | Mannatech | Rapid serum sugar biomarker assay of rheumatoid arthritis | G01N33/66 | G01N33/66|G01N2800/245|G01N2800/122|G01N2800/065|Y10T436/143333|G01N2800/042 | 6 | G01N33/00 | G01N33/00 | 1 | |
940636 | Sepsis | 패혈증 | 기타 세균성 질환 | A40-41 | 3157382 | mass index | 질량지수 | 1 | 4 | US | US00008889366B2 | 12/995772 | 20110171750 | 8889366 | 20090529 | 20110714 | 20141118 | 20110714 | Brahms | Marker for graft failure and mortality | G01N33/6893 | G01N33/6893|G01N33/74|G01N2333/585|G01N2800/245 | 4 | G01N33/53 | G01N33/53|G01N31/00|G01N33/74|G01N33/68 | 4 | |
211650 | Toxic shock syndrome | 독성쇼크증후군 | 기타 세균성 질환 | A48.3 | 1496653282 | group | 그룹 | 13 | 547 | US | US00005679369B | 08/467659 | 5679369 | 19950606 | 19971021 | 19971021 | McNeil-PPC | Additives to tampons | A61L15/20 | A61L15/20|Y10S604/904 | 2 | A61F13/02 | A61F13/02|A61L15/20 | 2 | |||
211731 | Mumps | 볼거리 | 기타 바이러스질환 | B26 | 1519313192 | group of frequency | 주파수 그룹 | 6 | 2 | US | US00005690692B | 08/787158 | 5690692 | 19970122 | 19971125 | 19971125 | Regeneration Technology | Bio-active frequency generator and method | A61N1/326 | A61N1/326|A61N1/40 | 2 | A61N1/32 | A61N1/32|G06Q50/00|G06Q30/00|A61N1/40|G09C1/00|G07B17/00|H04L9/32|G06Q10/00 | 8 | |||
212188 | Acute bronchitis | 급성 기관지염 | 호흡계통의 질환 | J20 | 2298510 | graft versus host | 이식편대숙주 | 1 | 6 | US | US20200306253A1 | 16/629390 | 20200306253 | 20180713 | 20201001 | 20201001 | Michael David Forrest | Therapeutic Modulators of the Reverse Mode of ATP Synthase | A61K31/53 | A61K31/53|C07D233/56|C07D233/61|A61P35/00|Y02A50/30|A61K31/4164|C07D403/06|C07D251/54 | 8 | A61K31/53 | A61K31/53|C07D233/61 | 2 | |||
940457 | colitis | 감염성 또는 패혈성 결장염 | 장감염질환 | A09.0.6.0 | 544620 | blocking group | 블록킹그룹 | 2 | 2 | US | US20150290295A1 | 14/685363 | 20150290295 | 20150413 | 20151015 | 20151015 | 1149336 Ontario | METHODS OF ENHANCING FUNCTIONING OF THE LARGE INTESTINE | A61K38/26 | A61K38/26|A61P9/10|A61P1/04|A61P1/00|C07K14/605|A61K49/0008|A61P29/00 | 7 | A61K38/26 | A61K38/26|A61K49/00|C07K14/605 | 3 | |||
940636 | Sepsis | 패혈증 | 기타 세균성 질환 | A40-41 | 63566504 | sepsis model | 패혈증 모델 | 27 | 26 | US | US20070042003A1 | 11/208143 | 20070042003 | 20050819 | 20070222 | 20070222 | Webber, Douglas, S.|Webber, Robert, J. | Method of effecting a mammalian model of sepsis, severe sepsis, or septic shock | A61K31/739 | A61K31/739 | 1 | A61K39/02 | A61K39/02|A61K31/739 | 2 | |||
211661 | Chancroid | 무른궤양 | 주로 성행위로 전파되는 감염 | A57 | 1607032903 | type of fabric | 직물의 종류 | 1 | 1 | US | US20050061333A1 | 10/667634 | 20050061333 | 20030922 | 20050324 | 20050324 | Hart Reginald Laral | Dermawear | A41B11/14 | A41B11/14 | 1 | A61F13/00 | A61F13/00 | 1 | |||
940836 | Noma | 노마 | 기타 스피로헤타질환 | A69.0.2 | 5144561 | sparse code multiple access | 스파스 코드 다중 액세스 | 3 | 8 | US | US00011115160B2 | 16/881810 | 20200374054 | 11115160 | 20200522 | 20201126 | 20210907 | 20201126 | TYBALT | Non-orthogonal multiple access | H04L5/0005 | H04L5/0005|H04J99/00 | 2 | H04J99/00 | H04J99/00|H04L5/00 | 2 | |
968867 | Syphilis | 매독 | 주로 성행위로 전파되는 감염 | A50-A53 | 5360355 | surface active agent | 표면활성제 | 1 | 10 | US | US20070004689A1 | 11/489263 | 20070004689 | 20060719 | 20070104 | 20070104 | EntreMed | Antiangiogenic agents | C07J1/00 | C07J1/00|C07J21/00 | 2 | A61K31/58 | A61K31/58|A61K31/56|C07J1/00|C07J21/00 | 4 | |||
211678 | Rickettsioses | 리케차병 | 리케차병 | A75-A79 | 1851162 | etiological agent | 원인 물질 | 17 | 4 | US | US00008084247B2 | 12/658214 | 20100151563 | 8084247 | 20100204 | 20100617 | 20111227 | 20100617 | American Sterilizer | Biological indicator | G01N33/54353 | G01N33/54353|C12Q1/22 | 2 | C12M1/34 | C12M1/34 | 1 | |
941051 | Vaccinia | 우두 | 피부 및 점막병변이 특징인 바이러스감염 | B08.0.3 | 1289631171 | agent in vitro | 시험관 내 에이전트 | 5 | 3 | US | US20090081639A1 | 12/156135 | 20090081639 | 20080530 | 20090326 | 20090326 | Genelux | Assay for sensitivity to chemotherapeutic agents | G01N33/57407 | G01N33/57407|G01N2800/52 | 2 | C12Q1/70 | C12Q1/70 | 1 | |||
968871 | hepatitis C | C형간염 | 바이러스간염 | B17.1|B18.2 | 5887589 | virus entry | 바이러스 진입 | 6 | 24 | US | US20220226292A1 | 17/578968 | 20220226292 | 20220119 | 20220721 | 20220721 | Indian Institute of Science | Antiviral Applications of Picolinic Acid and its Derivatives | A61K31/4402 | A61K31/4402|A61P31/16 | 2 | A61K31/4402 | A61K31/4402|A61P31/16 | 2 | |||
211673 | Other spirochaetal infections | 기타 스피로헤타감염 | 기타 스피로헤타질환 | A69 | 1404898877 | divalent linking group | 2가 연결기 | 3 | 1 | US | US00006177440B1 | 09/063066 | 6177440 | 19980421 | 20010123 | 20010123 | Eli Lilly and Company | Substituted tricyclics | C07D209/88 | C07D209/88 | 1 | C07D491/052 | C07D491/052|C07D209/88 | 2 | |||
211609 | Anthrax | 탄저병 | 특정 동물매개의 세균성 질환 | A22 | 2843594 | L type | L형 | 6 | 1 | US | US20080220441A1 | 11/974156 | 20080220441 | 20071010 | 20080911 | 20080911 | Icagen | Advanced drug development and manufacturing | G01N33/566 | G01N33/566|G01N2500/04|G01N2223/076|G01N23/223|G01N23/2204 | 5 | G01N33/53 | G01N33/53|G01N23/223|G01N21/76|G01N33/68 | 4 | |||
211774 | Protozoal diseases | 원충질환 | 원충질환 | B50-B64 | 1260556 | cytotoxic t lymphocyte response | 세포독성 T 림프구 반응 | 5 | 4 | US | US20020136733A1 | 10/042202 | 20020136733 | 20020111 | 20020926 | 20020926 | Oxxon Therapeutics | Malaria peptides | C07K14/445 | C07K14/445|Y02A50/30|A61K39/00 | 3 | C07K14/74 | C07K14/74|A61K39/00 | 2 | |||
211623 | Other bacterial diseases | 기타 세균성 질환 | 기타 세균성 질환 | A30-A49 | 1644298404 | area descriptor | 영역 설명자 | 10 | 2 | US | US20080040082A1 | 11/788079 | 20080040082 | 20070419 | 20080214 | 20080214 | P&G (Procter & Gamble) | Modeling systems for consumer goods | G06Q10/04 | G06Q10/04|G16C20/70|G16C20/50|G06Q10/067 | 4 | G06G7/48 | G06G7/48 | 1 | |||
211630 | Diphtheria | 디프테리아 | 기타 세균성 질환 | A36 | 5887816 | virus type | 바이러스 유형 | 1 | 58 | US | US20090214533A1 | 12/372106 | 20090214533 | 20090217 | 20090827 | 20090827 | Columbia University | METHODS FOR CONVERTING OR INDUCING PROTECTIVE IMMUNITY | C07K16/32 | C07K16/32|A61K2039/505|A61K39/00|A61P35/00 | 4 | A61K39/395 | A61K39/395|A61P35/00 | 2 | |||
211747 | Candidiasis | 칸디다증 | 진균증 | B37 | 2814278 | Java | 자바 | 1 | 1 | US | US20220364016A1 | 17/639759 | 20220364016 | 20200820 | 20221117 | 20221117 | Symrise | PERFUME OIL MIXTURE | C11B9/0034 | C11B9/0034 | 1 | C11B9/00 | C11B9/00 | 1 |
판매제공처 홈페이지 | 판매담당자 | 연락처 | 이메일 |
---|---|---|---|
www.BLT.kr | 특허법인BLT | 02-514-0104 | khpark@blt.kr |
제약 및 취소/환불 규정 안내 |
---|
데이터 상품은 디지털화된 상품의 특성상 반품, 취소, 환불 되지 않으나 데이터의 심각한 오류, 상이한 데이터에 한하여 구매자가 요구하는 경우 환불을 진행할 수 있습니다. |